Gene-Specific Therapy for Congenital Long QT Syndrome Are We There Yet?

被引：5
|
作者：
Arbelo, Elena [1 ]
Sarquella-Brugada, Georgia [2 ]
Brugada, Josep [1 ,2 ]
机构：
[1] Hosp Clin Barcelona, Cardiovasc Inst, Dept Cardiol, Barcelona, Spain
[2] Hosp San Joan de Deu, Dept Pediat Cardiol, Barcelona, Spain
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2016年 / 67卷 / 09期
关键词：
arrhythmia; mutation; sodium-channel blocker; sudden cardiac death; NA+ CHANNEL BLOCKADE; SCN5A; MANAGEMENT; MEXILETINE; MUTATIONS; GENOTYPE; EVENTS;
D O I：
10.1016/j.jacc.2015.12.030
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1059 / 1061
页数：3
相关论文
共 50 条
  • [1] Gene-Specific Therapy With Mexiletine Reduces Arrhythmic Events in Patients With Long QT Syndrome Type 3
    Mazzanti, Andrea
    Maragna, Riccardo
    Faragli, Alessandro
    Monteforte, Nicola
    Bloise, Raffaella
    Memmi, Mirella
    Novelli, Valeria
    Baiardi, Paola
    Bagnardi, Vincenzo
    Etheridge, Susan P.
    Napolitano, Carlo
    Priori, Silvia G.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (09) : 1053 - 1058
  • [2] Precision therapy in congenital long QT syndrome
    Neves, Raquel
    Bains, Sahej
    Bos, J. Martijn
    MacIntyre, Ciorsti
    Giudicessi, John R.
    Ackerman, Michael J.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2024, 34 (01) : 39 - 47
  • [3] Congenital long QT syndrome: a clinician's guide
    Lankaputhra, Malanka
    Voskoboinik, Aleksandr
    INTERNAL MEDICINE JOURNAL, 2021, 51 (12) : 1999 - 2011
  • [4] Implantable cardioverter defibrillator therapy for congenital long QT syndrome: A single-center experience
    Horner, Justin M.
    Kinoshita, Masayoshi
    Webster, Tracy L.
    Haglund, Carla M.
    Friedman, Paul A.
    Ackerman, Michael J.
    HEART RHYTHM, 2010, 7 (11) : 1616 - 1622
  • [5] Depressive symptoms in the congenital long QT syndrome
    Hintsa, Taina
    Keltikangas-Jarvinen, Liisa
    Puttonen, Sampsa
    Ravaja, Niklas
    Toivonen, Lauri
    Kontula, Kimmo
    Swan, Heikki
    ANNALS OF MEDICINE, 2009, 41 (07) : 516 - 521
  • [6] Risk Prediction in Women With Congenital Long QT Syndrome
    Goldenberg, Ilan
    Bos, J. Martijn
    Yoruk, Ayhan
    Chen, Anita Y.
    Lopes, Coeli
    Huang, David T.
    Kutyifa, Valentina
    Younis, Arwa
    Aktas, Mehmet K.
    Rosero, Spencer Z.
    McNitt, Scott
    Sotoodehnia, Nona
    Kudenchuk, Peter J.
    Rea, Thomas D.
    Arking, Dan E.
    Scott, Christopher G.
    Briske, Kaylie A.
    Sorensen, Katrina
    Ackerman, Michael J.
    Zareba, Wojciech
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (14):
  • [7] Influence of Pregnancy in Patients With Congenital Long QT Syndrome
    Garg, Lohit
    Garg, Jalaj
    Krishnamoorthy, Parasuram
    Ahnert, Amy
    Shah, Neeraj
    Dusaj, Raman S.
    Bozorgnia, Babak
    CARDIOLOGY IN REVIEW, 2017, 25 (04) : 197 - 201
  • [8] From gene-specific to function-specific risk stratification in long QT syndrome Type 2: implications for clinical management
    Crotti, Lia
    EUROPACE, 2023, 25 (04): : 1320 - 1322
  • [9] Long-term flecainide therapy in type 3 long QT syndrome
    Chorin, Ehud
    Taub, Rivki
    Medina, Aron
    Flint, Nir
    Viskin, Sami
    Benhorin, Jesaia
    EUROPACE, 2018, 20 (02): : 370 - 376
  • [10] Trafficking Defects and Gating Abnormalities of a Novel SCN5A Mutation Question Gene-Specific Therapy in Long QT Syndrome Type 3
    Ruan, Yanfei
    Denegri, Marco
    Liu, Nian
    Bachetti, Tiziana
    Seregni, Morena
    Morotti, Stefano
    Severi, Stefano
    Napolitano, Carlo
    Priori, Silvia G.
    CIRCULATION RESEARCH, 2010, 106 (08) : 1374 - U162
12345